Développement d'un système d'expression acellulaire à base d'extrait de germe de blé pour la production, la purification et la caractérisation structurale et fonctionnelle de protéines membranaires eucaryotes : application à la préparation des protéines du virus de l'hépatite C. |
|
Expression régulée de molécules thérapeutiques après détection de marqueurs pathologiques par des lymphocytes B reprogrammés génétiquement. |
|
Faut-il avoir peur des virus ? |
|
Functional characterization of the SARS-CoV-2 spike protein and syncytia formation |
|
Gene transfer using avian retroviral vectors: construction of avian mackaging celle lines, development of a nex method of vaccination using retroviral vectors. |
|
Genetic reprogramming of B cells for regulated expression of a therapeutic molecule upon disease biomarker recognition |
|
HCV assembly : from clustering of viral assembly factors to envelopment and lipidation of particles |
|
Identification et caractérisation de gènes induits par l’interféron modulant l’infection par le virus de la fièvre hémorragique de Crimée-Congo. |
|
In vitro study of hepatitis C virus association with host lipoproteins. |
|
Interaction between Nipah virus and its natural reservoir frugivore Pteropus bats : establishment of an experimental model. |
|
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity |
|
Masking of retroviral envelope functions by oligomerizing polypeptide adaptors. |
|
Measles virus envelope pseudotyped lentiviral vectors transduce quiescent human HSCs at an efficiency without precedent |
|
Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors. |
|
Membrane Fusion Assays for Studying Entry Hepatitis C Virus into Cells |
|
Modification de la glycoprotéine portée par les vecteurs rétroviraux pour favoriser le transfert de gènes dans les cellules quiescentes et le ciblage cellulaire |
|
Modification of murine leukemia virus particles and virion incorporation of heterologous proteins, as a strategy towards the development of retroviral vectors for in vivo gene therapy applications, anglais |
|
Molecular mechanisms of entry inhibitors of hepatitis C virus (HCV) and Silibinin Arbidol : hepatocyte microenvironment and HCV infection. |
|
The mouse IAPE endogenous retrovirus can infect cells through any of the five GPI-anchored EphrinA proteins. |
|
MuLV packaging systems as models for estimating/measuring retrovirus recombination frequency. |
|
Mutations in the H, F, or M Proteins Can Facilitate Resistance of Measles Virus to Neutralizing Human Anti-MV Sera. |
|
The mycotoxin aflatoxin B1 stimulates Epstein-Barr virus-induced B-cell transformation in in vitro and in vivo experimental models. |
|
Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor. |
|
Neutralizing antibodies to hepatitis C virus |
|
Nipah virus uses leukocytes for efficient dissemination within a host |
|
Nouveaux pseudotypes rétroviraux basés sur les glycoprotéines d'enveloppe de paramyxovirus : applications biothérapeutiques en thérapie génique et en vaccinologie |
|
A novel BaEVRless-pseudotyped γ-globin lentiviral vector drives high and stable HbF expression and improves thalassemic erythropoiesis in vitro |
|
A novel lentiviral vector targets gene transfer into human hematopoietic stem cells in marrow from patients with bone marrow failure syndrome and in vivo in humanized mice. |
|
Optimization of a bivalent HBV-HCV vaccine by its association with apolipoprotein E and sequential immunizations with particles bearing HCV envelope proteins of various genotypes. |
|
Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. |
|
A Point Mutation in the N-Terminal Amphipathic Helix α0 in NS3 Promotes Hepatitis C Virus Assembly by Altering Core Localization to the Endoplasmic Reticulum and Facilitating Virus Budding |
|
The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination |
|
Preliminary evidence for hdv exposure in apparently non-HBV-infected patients |
|
Primaquine as an innovative and targeted therapeutic strategy for HHV-8-associated diseases. |
|
La Primaquine, une thérapie innovante et ciblée pour les pathologies associées à l'infection par l'Herpèsvirus humain 8 |
|
Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes |
|
Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines. |
|
La protéine Core du virus de l'hépatite B est le déterminant majeur responsable de l'inhibition précoce de la réponse IFN dans les hépatocytes |
|
A Recurrent Activating Missense Mutation in Waldenström Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances Proliferation |
|
Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors |
|
Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein |
|
Retargeting gene delivery using surface-engineered retroviral vector particles. |
|
Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin. |
|
Retroviral glycoproteines : intracellular traficking and viral assembly. |
|
Retroviral pseudotype : basic mechanisms of assembly and properties for gene transfer. |
|
Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope |
|
Rôle des récepteurs à la phosphatidylsérine lors de l'infection par les flavivirus. |
|
Rôle direct du virus de l'hépatite C dans fibrogenèse hépatique et les mécanismes asociés |
|
The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles |
|
Le « Scavenger Récepteur B1 » est un facteur multifonctionnel de l'entrée cellulaire pour le virus de l'hépatite C. |
|
The Scavenger Receptor B1 is a multifunctional HCV entry factor |
|
Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase. |
|
Significant redox insensitivity of the functions of the SARS-CoV spike glycoprotein: comparison with HIV envelope. |
|
Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle. |
|
Strategies for retargeted gene delivery using vectors derived from lentiviruses. |
|
Studying HCV cell entry with HCV pseudoparticles |
|
Surface engineering of lentiviral vectors for gene transfer into gene therapy target cells |
|
Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles. |
|
The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus |
|
TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression |
|
Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure. |
|
Towards Physiologically and Tightly Regulated Vectored Antibody Therapies |
|
Tranfert de gènes par des vecteurs rétroviraux aviaires : élaboration de lignées cellulaires transcomplémentantes aviaires, mise au point d'un nouveau procédé de vaccination utilisation des vecteurs rétroviraux |
|
Transposable elements behavior following viral genomic stress in Drosophila melanogaster inbred line. |
|
TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells |
|
Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell Leukemia. |
|
Unraveling the details of the entry of hepatitis C virus into hepatocytic cells by electron microscopy imaging. |
|
Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumors. |
|
Use of helper cells with two host ranges to generate high-titer retroviral vectors. |
|
Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing |
|
Vectors derived from simian immunodeficiency virus (SIV). |
|
Viral and cellular mechanisms study that regulate VIH-1 infection. |
|
Viral vectors: from virology to transgene expression |
|
Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice |
|